Permeon Biologics' Series B Round

Permeon Biologics raised a round of funding on December 29, 2011.

Permeon Biologics is developing a panel of human proteins that exhibit potent activity as Intraphilins for intracellular biologics in vivo. As part of developing intracellular biologics, Permeon's Int…

Articles about Permeon Biologics' Series B Round: